Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SRXHthis companySRX Global Inc.	$0.88	-0.21×	22.88×	1.43×	-1.56×	-1748.8%	23.4%	-174.6%	-688.8%	-11058.0%	-233.7%	-87.4%	10.99×	-0.4×	-18.16×	2.29×	0.0%	5	2.58	2	C
AEONAEON Biopharma, Inc.	$0.18	-0.28×	-0.2×	0×	-2.69×	-1979.4%	0.0%	0.0%	0.0%	71.3%	1180.0%	-158.6%	-0.65×	-2.02×	0×	0.49×	0.0%	2	-129.4	2	C
BOLTBolt Biotherapeutics, Inc.	$6.36	-0.31×	0.39×	1.33×	-0.67×	-1444.2%	80.6%	-450.1%	-433.7%	-125.9%	-67.7%	-390.3%	0.87×	-0.35×	0×	3.59×	0.0%	2	-18.09	2	C
CLRBCellectar Biosciences, Inc.	$1.30	-0.35×	0.78×	0×	0.24×	240.1%	0.0%	0.0%	0.0%	-219.7%	-222.5%	-300.5%	0.04×	0.59×	0×	2.96×	0.0%	2	-10.71	3	B
MRKRMarker Therapeutics, Inc.	$1.02	-1.89×	1.36×	0×	-0.54×	6.2%	0.0%	0.0%	0.0%	-72.4%	-76.6%	-52.7%	0×	1.29×	0×	8.39×	0.0%	2	-41.23	2	C
TNONTenon Medical, Inc.	$1.76	-0.56×	1.39×	1.78×	-0.28×	-128899.7%	59.8%	-324.3%	-318.4%	-249.1%	-166.4%	-156.8%	0.03×	0.3×	0×	2.11×	0.0%	3	-16.68	2	C
Peer median	—	-0.35×	0.78×	0×	-0.54×	-1444.2%	0.0%	0.0%	0.0%	-125.9%	-76.6%	-158.6%	0.03×	0.3×	0×	2.96×	0.0%	2	-18.09	2	—